Search
for
Sort by
Research 31–60 of 1000+
- Poster Abstracts
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Topical absorption and systemic toxicity
- Interpretation of Laboratory Data and General Physical Examination by Pharmacists
- Guidelines for the Use of Acitretin in Psoriasis
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Mice with Alopecia, Osteoporosis, and Systemic Amyloidosis Due to Mutation in Zdhhc13, a Gene Coding for Palmitoyl Acyltransferase
- Circadian clocks: from stem cells to tissue homeostasis and regeneration
- Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels
- Potassium channel openers: therapeutic potential in cardiology and medicine
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Impending central retinal vein occlusion and granulomatous uveitis in a patient with Satoyoshi syndrome
- Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- The Role of PPARβ/δ-Related Lipid Metabolism in High-Altitude Adaptation of Yak Coat Based on Proteomics and Metabolomics
- Baricitinib for the Treatment of Alopecia Areata
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- JAK inhibition decreases the autoimmune burden in Down syndrome
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Friend or foe: A systematic review of dupilumab and alopecia areata
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Industry updates in advanced therapy medicinal products and regenerative medicine – March 2026